US Stock MarketDetailed Quotes

SEER Seer Inc

Watchlist
  • 2.100
  • -0.100-4.55%
Close Feb 28 16:00 ET
  • 2.110
  • +0.010+0.48%
Post 16:07 ET
124.17MMarket Cap-1.51P/E (TTM)

Seer Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Seer Inc Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
3.95M
-4.00M
-7.95M
Miss Est.
-11.00%
-190.13%
-201.27%
EPS
-0.38
-0.37
+<0.01
Beat Est.
-34.16%
-32.14%
+1.46%
Analyst Rating
Buy

Feb 27, 2025

Seer Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.050M--
--2025/Q1-- / 3.250M--
Feb 27, 20252024/Q44.000M / 3.950M--
Nov 6, 20242024/Q34.032M / 3.150M--
Aug 8, 20242024/Q23.072M / 3.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.050M--
--2025/Q1-- / 3.250M--
Feb 27, 20252024/Q44.000M / 3.950M--
Nov 6, 20242024/Q34.032M / 3.150M--
Aug 8, 20242024/Q23.072M / 3.000M--

Unlock Free Earnings Estimates

Seer Inc Earnings Reports

  • Seer Inc | 8-K: Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook

    Feb 27 16:33 ET

  • Seer Inc | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:22 ET

  • Seer Inc | 8-K: Seer Reports Third Quarter 2024 Financial Results

    Nov 6, 2024 16:15 ET

  • Seer Inc | 8-K: Seer Reports Second Quarter 2024 Financial Results

    Aug 8, 2024 16:45 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 27, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data